Lengo Therapeutics
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
Funding reportedLast round: Series A
Follow Lengo Therapeutics and see its new rounds in your feed.Start following
What company datasets say Lengo Therapeutics raised
Funding, as reported
Reported in all15Min the source's currency
Rounds1
Last roundSeries A
Last round dateMay 2020
Investors listed1
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Lengo Therapeutics in front of investors. Or tell us what we have wrong.